Life Science Intelligence

Life Science Intelligence (LSI) helps medtech executives make better strategic decisions by delivering unique market data and business insights. For over 13 years LSI has been working with industry giants – Johnson & Johnson, Medtronic, Abbott, Stryker, Cardinal, Boston Scientific, and Becton Dickinson, among others. LSI products are also leveraged by the most successful start-ups, innovators, investors, and service companies that compete in medtech. LSI is the organizer of The Emerging Medtech Summit held annually in Southern California.
Find me on:

Recent Posts

Insulin Pumps Lead the Way in an Otherwise Mature Market Segment

Posted by Life Science Intelligence on May 9, 2022 7:00:00 AM

 

Topic/Category: Drug Delivery, Growth & Challenges

Since its discovery over 100 years ago, insulin has experienced marked growth in the drug delivery market. With so many insulin delivery options available today, this market segment still presents many opportunities for growth while already leading the wider drug delivery market. Insulin pumps are poised to remain near the top of the drug delivery market throughout 2022 as these products experience new market trends and innovations throughout the year and into 2023.

Read More

Topics: Drug Delivery

After Recovery From COVID-19 in 2021, General Surgical Procedures Remain Basically Flat in the US

Posted by Life Science Intelligence on May 2, 2022 7:00:00 AM

 

Topic/Category: Surgery/Procedures

The global impact of COVID-19 is a chain reaction felt across the entire healthcare industry. According to Medtech market intelligence provider, Life Science Intelligence (LSI), many of the largest medical device & diagnostics companies were suddenly at risk of losing revenue by as much as 90%, while others, like manufacturers of medical masks and ventilators, and producers of COVID-19 diagnostics, saw a doubling in profits that exceeded supply. This chain reaction interconnects how medical equipment, supplies, and technology directly tie to the pandemic’s effect on general surgical procedures in the US.

Read More

Topics: COVID-19, Surgery, Procedures

Crossroads Extremity Systems Acquired by Johnson & Johnson Subsidy DePuy Synthes

Posted by Life Science Intelligence on Apr 25, 2022 9:02:04 AM

 

Topic/Category: Ortho/Spine, Deals

On February 11, 2022, CrossRoads Extremity Systems was acquired by DePuy Synthes, a subsidiary of Johnson & Johnson, for an undisclosed sum. According to LSI’s MedtechPro Startup Tracker from Medtech Pro, the company had raised $19.7 million in funding from Runway Growth Capital and other investors.

Read More

Topics: Insider, Strategics, Medtech, Medtech Innovation Weekly Update

New Era of Smart Surgery, Innovation, and Market Growth

Posted by Life Science Intelligence on Mar 23, 2022 7:57:36 AM

Topic/Category: Digital Surgery

While surgical markets are beginning to rebound from the negative impact of COVID-19, recent advances in digital technologies—including artificial intelligence (AI), machine learning, and augmented/virtual reality (AR/VR)—are propelling market growth to levels not seen in years, advancing revenues more than fourfold since 2014.

Read More

Growth & Challenges in the Wound Care Devices Market

Posted by Life Science Intelligence on Mar 8, 2022 7:37:42 AM

Topic/Category: Wound Care, Growth & Challenges

As new variants come and go, COVID-19 continues to impact elective medical procedures, and wound care is no exception. Despite the ubiquitous use of wound closure technologies throughout medicine, especially in emergency care, this market segment was hit hard by the COVID pandemic. This is because many surgical procedures are considered elective or expedited, and as a result, many were delayed into 2021. Outside of trauma surgeries, most wound closure devices are used in surgeries and other procedures that are likely to be considered elective.

Read More

Neuromodulation Startup CereGate Poised to Shakeup Medtech Industry

Posted by Life Science Intelligence on Feb 21, 2022 7:00:00 AM

Topic/Category: Neuromodulation, Deals

Innovative neuromodulation startup, CereGate is developing therapeutic solutions using a brain-computer interface that is ripe for investment and future strategic partnerships. Using implanted electrodes, CereGate gathers sensory data and acts as a communications portal to the patient’s neurological system. The goal is to make the system useful for patients with sensory deprivation issues or neurological disorders by gathering information directly from the human brain, which could be used to operate external devices or even the patient’s own body. The company states that its goal is to allow patients to use their own power to improve their condition. At present, the focus is on helping patients with Parkinson’s disease improve their gait, using brain stimulation waveforms to mitigate the freezing of gait problems that Parkinson’s patients experience (See Medtech Pro Startup Tracker). 

Read More

While Neurostimulation Implants Were Significantly Impacted by COVID-19, Emerging Minimally or Non-Invasive Procedures Expected to Grow

Posted by Life Science Intelligence on Feb 15, 2022 7:00:00 AM

Topic/Category: Neuromodulation, Procedures

Since the early 19th century, it’s been known that the brain and nervous system works via the transmission of electrical signals. Since that time, scientists have been interested in using electrical signals to impact the brain and possibly offer treatments for various illnesses and conditions. This became a practical idea in the 20th century, but progress was slow, and the field stagnated for many decades.

Read More

COVID-19’s Devastating Impact on Cardiovascular Procedures

Posted by Life Science Intelligence on Feb 14, 2022 7:00:00 AM

Topic/Category: Cardiovascular Procedures

While the world has been focused on the devastating impact of COVID-19, cardiovascular disease remains a leading cause of death and disability in the developed world. In the United States alone, while 345,323 people died from COVID in 2020, 690,882 — twice as many — died from heart disease. Moreover, statistics show that cardiovascular disease is a significant comorbidity when it comes to hospitalization and death from COVID-19, meaning widespread heart disease also worsens health outcomes related to the pandemic.

Read More

A Growing Market? Neuromodulation Market Rebounds Strongly Despite COVID-19 Impacts

Posted by Life Science Intelligence on Feb 8, 2022 7:00:00 AM

Topic/Category: Neuromodulation, Growth & Challenges

With the announcement of Elon Musk’s brain-computer start-up Neuralink’s recent raise of $205 million dominating the news, you’ve probably been hearing Elon Musk talking about implanting a chip in his brain to interface with the internet. While Musk’s vision may seem part science-fiction and part wishful thinking, an exciting branch of medicine known as neuromodulation is having a significant impact on the well-being of patients.

Read More

Why Has the Percutaneous Atherectomy Devices Market Continued to Grow Despite COVID-19?

Posted by Life Science Intelligence on Feb 7, 2022 7:00:00 AM

Topic/Category: Cardiovascular Growth & Challenges

Understanding the Market Driver: Cardiovascular Disease

Cardiovascular disease remains a leading cause of death and disability worldwide, contributing to the second-largest Medtech market, Cardiovascular at $58.2 billion with a growth of 7.93% (Medtech Pro Market Summary Projection).  While the focus is usually on the dramatic effects of heart attack and stroke, plaque buildup in arteries also leads to serious complications in the extremities. Many people suffer from muscle cramps, leg weakness, and other issues as a result of circulation problems. These issues are not just about discomfort - they can also compound other health problems like diabetes and heart disease. Buildup of fatty deposits in the arteries supplying the legs can by discourage regular exercise and physical activity due to pain and muscle cramping. Poor circulation in the lower legs can also lead to slower wound healing, infection and even amputation. Collectively, plaque buildup in the extremities is known as peripheral arterial disease, or PAD.

Read More